Singapore’s Ministry of Health Commits SG$200 Million to AI-Driven Healthcare Innovations

The Singaporean Ministry of Health (MOH) has announced a significant investment of SG$200 million (approximately $150 million) over the next five years to enhance the implementation of AI technologies across the country’s healthcare system. This financial boost is part of the MOH Health Innovation Fund, aimed at advancing technological innovations and expanding AI integration into system-wide, national projects.

Key Initiatives Supported by the Investment:

1. Generative AI for Record Automation: A major focus of the funding will be a generative AI project designed to automate the updating of medical records. The MOH plans to roll out this project across the public healthcare system by the end of 2025, with the goal of streamlining administrative tasks such as documentation and the summarisation of medical records.
2. AI in Medical Imaging: The MOH will also invest in medical imaging AI for early detection of breast cancer. This technology, currently undergoing validation, is expected to be adopted as part of a national subsidised screening programme by the end of 2025. The initiative will enhance early detection and diagnosis through advanced AI-assisted imaging tools.

Broader Trends in Singapore’s AI-Driven Healthcare:

Singapore’s healthcare system has been making strides in integrating AI and generative AI (genAI) technologies, backed by the government. The national health tech agency Synapxe has expanded its partnership with Microsoft, working on projects like Secure GPT for Healthcare Professionals, which develops large language models (LLMs) for healthcare applications. The National University Health System (NUHS) has also developed RUSSELL-GPT, an AI chatbot that summarises patient case notes and generates referral letters.

Additionally, Singapore General Hospital is exploring genAI use in pre-surgery assessments, and hospitals under SingHealth have adopted chest X-ray analysis AI through AimSG, a national radiology AI platform. The platform, launched last year, allows hospitals to integrate validated AI tools into their workflows.

3. Genetic Testing Programme: The MOH also announced plans to launch a national genetic testing programme by mid-2025, with a focus on Familial Hypercholesterolemia, a genetic condition affecting cholesterol levels. This marks another step towards incorporating advanced technology into personalised healthcare.

Strengthening AI Governance:

As AI becomes more central to Singapore’s healthcare system, the MOH is committed to improving national governance for AI use in healthcare. The ministry emphasized the need to balance innovation with safety, ensuring that new AI solutions are implemented securely and deliver safe care to patients.

Conclusion: Singapore’s investment in AI-driven healthcare innovations demonstrates its forward-thinking approach to enhancing healthcare delivery. With a focus on automation, early detection, and improving overall patient care

Source: Business Standard